Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
This NIH R21 opportunity supports translational research to improve safe, effective precision therapeutics for pregnant and lactating people, fetuses, neonates, and children/adolescents. Projects should develop tools, models, biomarkers, and/or new or repurposed therapies that better predict drug exposure, effectiveness, and adverse risks across pregnancy, lactation, and pediatric development.…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
U.S. Food and Drug Administration (FDA) In Vitro and In Vivo Bioequivalence Fellowship
U.S. Food and Drug Administration
-
Collaborations to Enhance Drug Development and Regulatory Science
Food and Drug Administration
-
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
Food and Drug Administration
-
Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics
Food and Drug Administration
-
Novel approaches to support therapeutic development in ultra-rare cancers
Food and Drug Administration
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers